3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 3
1
Phase 2
1
Phase 1/2
1
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Conditions
Mesothelioma, Malignant
1
Interventions
Pemetrexed
7
Cisplatin
7
Cyclophosphamide
5
pembrolizumab
4
fludarabine
4
Platinum
3
Drug Therapy
3
aldesleukin
2
Nivolumab
2
Ipilimumab
2
Interleukin-2
2
1,2-diaminocyclohexaneplatinum II citrate
2
vatalanib
1
spartalizumab
1
regorafenib
1
napabucasin
1
methoxyamine
1
fludarabine phosphate
1
enzalutamide
1
cediranib
1
avelumab
1
atezolizumab
1
anetumab ravtansine
1
Vorinostat
1
Thiostrepton
1
Tetrahydrouridine
1
Radiosurgery
1
Megestrol Acetate
1
Levoleucovorin
1
Leucovorin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Mesothelioma, Malignant
×
Cerebral Decortication
×
Clear all
NCT07121374
2025-08-13
NECIM
University Hospital, Antwerp
Phase 1/2
Recruiting
37 enrolled